1Spechler SJ. Barrett’s esophagus. N Engl J Med. 2002;346(11):836-42.
2Dymedex Market Development Consulting, Strategic Market Assessment, Barrx, 30 de outubro de 2014. Referências 1, 4,5, 10, 11, 13, 20, 23, 25, 27, 28, 54-57, 80, 87 e 97 da lista de citação completa, acesse https://www.medtronic.com/content/dam/covidien/library/us/en/product/ablation-systems/barrx-rfa-system-gerd-dymedex-reference-information-sheet.pdf
3Vaezi M, Zehrai A, Yuksel E, Testing for refractory gastroesophageal reflux disease, ASGE Leading Edge, 2012 Vol 2, No 2, 1-13, American Society Gastroenterology Endoscopy, Página 1
4Spechler SJ, Souza RF. Barrett’s Esophagus. N Engl J Med. 2014;371(9):836-45.
5Turati F, Tramacere I, La Vecchia C, Negri E. A meta-analysis of body mass index and esophageal and gastric cardia adenocarcinoma. Ann Oncol. 2013;24(3):609-17.
6Evans JA, Early DS, Fukami N, et al. The role of endoscopy in Barrett’s esophagus and other premalignant conditions of the esophagus. Gastrointestinal Endosc. 2012;27(6):1087-94
7Shaheen NJ, Sharma P, Overholt BF, et al. Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med. 2009;360(22):2277-88.
8Chak A, Lee T, Kinnard MF, et al. Familial aggregation of Barrett’s oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults. GUT. 2002;51(3):323-8.
9Anaparthy R, Gaddam S, Kanakadandi V, et al. Association Between Length of Barrett’s Esophagus and Risk of High- Grade Dysplasia or Adenocarcinoma in Patients Without Dysplasia. Clin Gastroenterol Hepatol. 2013;11(11):1430-6.
10Coleman HG, Bhat S, Murray LJ, McManus D, Gavin AT, Johnston BT. Increasing incidence of Barrett’s oesophagus: a population-based study. Eur J Epidem. 2011;26(9):739-45.
11Phoa KN, van Vilsteren FG, Pouw R E, Weusten BL, et al. Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial. JAMA. 2014 Mar 26;311(12):1209-17.
12Canadian Cancer Society, Canadian Cancer Statistic 2016, Special Topic: HPV-associated cancers